Effective-Component Compatibility of Bufei Yishen Formula (ECC-BYF) III Inhibits Mucus Hypersecretion by BEAS-2B Cells via miR-146a-5p-Mediated Regulation of the EGFR/MEK/ERK Pathway
Yumeng Wei,1,* Jindi Ma1,2,* 1Traditional Chinese Medicine (Zhongjing) School, Henan University of Chinese Medicine, Zhengzhou, People’s Republic of China; 2Collaborative Innovation Center for Chinese Medicine and Respiratory Diseases Co-Constructed by Henan Province and Education Ministry o...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2025-03-01
|
| Серии: | International Journal of COPD |
| Предметы: | |
| Online-ссылка: | https://www.dovepress.com/effective-component-compatibility-of-bufei-yishen-formula-ecc-byf-iii--peer-reviewed-fulltext-article-COPD |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|